--- schema_version: "secwatch.filing_event.v1" accession: "0001683168-24-007019" form_type: "8-K/A" ticker: "BRGX" cik: "0001593184" company_name: "BIOREGENX, INC." filed_at: "2024-10-09T23:59:59+00:00" generated_at: "2026-05-30T17:19:47.003630+00:00" event_type: "m_and_a" sentiment: "negative" materiality_score: 0.75 calibrated_materiality_score: 0.75 confidence: "high" source: SEC EDGAR --- # BioRegenx completes reverse merger; posts $3.6M net loss in 2023 with going concern doubt ## Summary - Merger effective March 8, 2024: BioRegenx merged into Findit; registrant renamed BioRegenx, Inc. - Exchanged 851.98M shares and 3,800 Series A preferred for 90% voting control; retired prior preferred and 172.2M common shares. - Audited 2023 results: net loss $3.6M, sales $3.41M, stockholders' deficit $2.07M; auditor flags going concern. - New leadership: William Resides CEO/Interim CFO; new board of 7 directors appointed (8 total including Thomas Powers). - Authorized common increased to 1.5B shares; Series A preferred voting rights corrected to 2,500 votes per share. ## SEC filing metadata - accession: 0001683168-24-007019 - form_type: 8-K/A - ticker: BRGX - cik: 0001593184 - company_name: BIOREGENX, INC. - filed_at: 2024-10-09T23:59:59+00:00 - event_type: m_and_a - sentiment: negative - materiality_score: 0.75 - calibrated_materiality_score: 0.75 - confidence: high - sec_items: 2.01, 3.02, 5.01, 5.02, 5.03, 9.01 - EDGAR index: https://www.sec.gov/Archives/edgar/data/1593184/000168316824007019/0001683168-24-007019-index.htm - EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1593184/000168316824007019/bioregenx_8ka.htm ## Machine-readable alternates - HTML: https://secwatch.observer/filing/0001683168-24-007019 - JSON: https://secwatch.observer/filing/0001683168-24-007019.json - Plain text: https://secwatch.observer/filing/0001683168-24-007019.txt ## Key facts - Executive change Gary Hennerberg was appointed as Director at BIOREGENX, INC.. - Action: appointed - Role: Director source text: the following directors were appointed to join Thomas Powers on the Board of Directors: William Resides Robert Doran Sherri Adams Gary Hennerberg Suzanne Bird Jody Walker Gary Kiss evidence_url: https://www.sec.gov/Archives/edgar/data/1593184/000168316824007019/0001683168-24-007019-index.htm - Executive change Gary Hennerberg was appointed as Secretary at BIOREGENX, INC.. - Action: appointed - Role: Secretary source text: Gary Hennerberg – Secretary evidence_url: https://www.sec.gov/Archives/edgar/data/1593184/000168316824007019/0001683168-24-007019-index.htm - Executive change Jody Walker was appointed as Director at BIOREGENX, INC.. - Action: appointed - Role: Director source text: the following directors were appointed to join Thomas Powers on the Board of Directors: William Resides Robert Doran Sherri Adams Gary Hennerberg Suzanne Bird Jody Walker Gary Kiss evidence_url: https://www.sec.gov/Archives/edgar/data/1593184/000168316824007019/0001683168-24-007019-index.htm - Executive change Robert Doran was appointed as Executive Vice President at BIOREGENX, INC.. - Action: appointed - Role: Executive Vice President source text: Robert Doran – Executive Vice President evidence_url: https://www.sec.gov/Archives/edgar/data/1593184/000168316824007019/0001683168-24-007019-index.htm - Executive change Sherri Adams was appointed as Director at BIOREGENX, INC.. - Action: appointed - Role: Director source text: the following directors were appointed to join Thomas Powers on the Board of Directors: William Resides Robert Doran Sherri Adams Gary Hennerberg Suzanne Bird Jody Walker Gary Kiss evidence_url: https://www.sec.gov/Archives/edgar/data/1593184/000168316824007019/0001683168-24-007019-index.htm - Executive change Sherri Adams was appointed as Chief Operating Officer at BIOREGENX, INC.. - Action: appointed - Role: Chief Operating Officer source text: Sherri Adams – Chief Operating Officer evidence_url: https://www.sec.gov/Archives/edgar/data/1593184/000168316824007019/0001683168-24-007019-index.htm - Executive change Robert Doran was appointed as Director at BIOREGENX, INC.. - Action: appointed - Role: Director source text: the following directors were appointed to join Thomas Powers on the Board of Directors: William Resides Robert Doran Sherri Adams Gary Hennerberg Suzanne Bird Jody Walker Gary Kiss evidence_url: https://www.sec.gov/Archives/edgar/data/1593184/000168316824007019/0001683168-24-007019-index.htm - Executive change Thomas Powers resigned as other_named_officer at BIOREGENX, INC.. - Action: resigned source text: Effective March 8, 2024, Raymond Firth and Thomas Powers resigned as officers of the Registrant evidence_url: https://www.sec.gov/Archives/edgar/data/1593184/000168316824007019/0001683168-24-007019-index.htm - Executive change William Resides was appointed as Interim Financial Officer at BIOREGENX, INC.. - Action: appointed - Role: Interim Financial Officer source text: William Resides – Chief Executive Officer, Interim Financial Officer evidence_url: https://www.sec.gov/Archives/edgar/data/1593184/000168316824007019/0001683168-24-007019-index.htm - Executive change Suzanne Bird was appointed as Director at BIOREGENX, INC.. - Action: appointed - Role: Director source text: the following directors were appointed to join Thomas Powers on the Board of Directors: William Resides Robert Doran Sherri Adams Gary Hennerberg Suzanne Bird Jody Walker Gary Kiss evidence_url: https://www.sec.gov/Archives/edgar/data/1593184/000168316824007019/0001683168-24-007019-index.htm - Executive change Raymond Firth resigned as other_named_officer at BIOREGENX, INC.. - Action: resigned source text: Effective March 8, 2024, Raymond Firth and Thomas Powers resigned as officers of the Registrant evidence_url: https://www.sec.gov/Archives/edgar/data/1593184/000168316824007019/0001683168-24-007019-index.htm - Executive change William Resides was appointed as Director at BIOREGENX, INC.. - Action: appointed - Role: Director source text: the following directors were appointed to join Thomas Powers on the Board of Directors: William Resides Robert Doran Sherri Adams Gary Hennerberg Suzanne Bird Jody Walker Gary Kiss evidence_url: https://www.sec.gov/Archives/edgar/data/1593184/000168316824007019/0001683168-24-007019-index.htm - Executive change William Resides was appointed as Chief Executive Officer at BIOREGENX, INC.. - Action: appointed - Role: Chief Executive Officer source text: William Resides – Chief Executive Officer, Interim Financial Officer evidence_url: https://www.sec.gov/Archives/edgar/data/1593184/000168316824007019/0001683168-24-007019-index.htm - Executive change Raymond Firth resigned as director at BIOREGENX, INC.. - Action: resigned source text: Effective March 8, 2024, Raymond Firth resigned as a director of the Registrant evidence_url: https://www.sec.gov/Archives/edgar/data/1593184/000168316824007019/0001683168-24-007019-index.htm - Executive change Gary Kiss was appointed as Director at BIOREGENX, INC.. - Action: appointed - Role: Director source text: the following directors were appointed to join Thomas Powers on the Board of Directors: William Resides Robert Doran Sherri Adams Gary Hennerberg Suzanne Bird Jody Walker Gary Kiss evidence_url: https://www.sec.gov/Archives/edgar/data/1593184/000168316824007019/0001683168-24-007019-index.htm This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.